Skip to main content

Table 3 Origins of the DBS used to define the clinical performances of the K13 bMx prototype (from DBS to results) in field conditions

From: A novel field-based molecular assay to detect validated artemisinin-resistant k13 mutants

Plasmodium species

Clinical status

Asia

Africa

Total

Cambodia

Myanmar

Malaria-free

10

  

10

P. falciparum

Symptomatic

296

221

31

548

Asymptomatic

63

  

63

P. falciparum/P. vivax

Symptomatic

17

  

17

Asymptomatic

2

  

2

P. vivax

Symptomatic

1

  

1

Asymptomatic

1

  

1

Total

 

390

221

31

642